🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to examine how well a medication call...
Status
Recruiting
Location
University of Arizona
Start Date
2026-08
Trial ID
NCT07623135
Treatments Being Tested
Study ITI-007-037 is a Phase 1b, open-label study to evaluate the safety, t...
Status
Completed
Location
Collaborative Neuroscience Research, LLC
Start Date
2024-08-23
Trial ID
NCT06627413
The study will evaluate the efficacy and safety of ITI-007 adjunctive to li...
Status
Completed
Location
Clinical Site
Start Date
2016-03-07
Trial ID
NCT02600507
Treatments Being Tested
The purpose of this study is to determine the relationship between ITI-007 ...
Status
Completed
Location
Johns Hopkins Medical Institutions
Start Date
2014-10
Trial ID
NCT02288845
Treatments Being Tested
This is a multicenter, open-label, fixed dose, 26 week study of patients wi...
Status
Completed
Location
Clinical Site
Start Date
2021-10-08
Trial ID
NCT05061719
Treatments Being Tested
This study is looking to determine if Lumateperone improves motivation in p...
Status
Recruiting
Location
LSU Health Shreveport
Start Date
2024-06
Trial ID
NCT06482554
Treatments Being Tested
The purpose of the study is to assess how well each dose of lumateperone (D...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-20
Trial ID
NCT07747389
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Clinical Site
Start Date
2021-07-30
Trial ID
NCT04985942
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled study i...
Status
Recruiting
Location
Harmonex Neuroscience Research
Start Date
2024-11-22
Trial ID
NCT06690398
Treatments Being Tested
A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral D...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02078310